Mark E. Polhemus

2.7k total citations
44 papers, 1.2k citations indexed

About

Mark E. Polhemus is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Virology. According to data from OpenAlex, Mark E. Polhemus has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Public Health, Environmental and Occupational Health, 11 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in Mark E. Polhemus's work include Mosquito-borne diseases and control (21 papers), Malaria Research and Control (20 papers) and Viral Infections and Vectors (5 papers). Mark E. Polhemus is often cited by papers focused on Mosquito-borne diseases and control (21 papers), Malaria Research and Control (20 papers) and Viral Infections and Vectors (5 papers). Mark E. Polhemus collaborates with scholars based in United States, Kenya and Ecuador. Mark E. Polhemus's co-authors include Christian F. Ockenhouse, Naomi Aronson, Glenn Wortmann, Timothy P. Endy, Anna M. Stewart‐Ibarra, Anjali Yadava, Peter J. Weina, Sadie J. Ryan, Ronald C. Neafie and Heikyung Suh and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The FASEB Journal.

In The Last Decade

Mark E. Polhemus

44 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mark E. Polhemus

Since Specialization

Citations

This map shows the geographic impact of Mark E. Polhemus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Polhemus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Polhemus more than expected).

Fields of papers citing papers by Mark E. Polhemus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Polhemus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Polhemus. The network helps show where Mark E. Polhemus may publish in the future.

Co-authorship network of co-authors of Mark E. Polhemus

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Polhemus. A scholar is included among the top collaborators of Mark E. Polhemus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Polhemus. Mark E. Polhemus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults 2024 ·Vaccine ·James F. Cummings, Mark E. Polhemus, Kent E. Kester, Chris Ockenhouse, Robert A. Gasser, Patrick J. Coyne, Glenn Wortmann, Robin Nielsen, Kurt E. Schaecher, Christie A. Holland, Urszula Krzych, Nadia Tornieporth, Lorraine Soisson, Evelina Angov, D. Gray Heppner	2
2	Exploring the utility of social-ecological and entomological risk factors for dengue infection as surveillance indicators in the dengue hyper-endemic city of Machala, Ecuador 2021 ·PLoS neglected tropical diseases ·Catherine A. Lippi, Anna M. Stewart‐Ibarra, Timothy P. Endy, (unknown), (unknown), (unknown), Mark E. Polhemus, Efraín Beltrán‐Ayala, Sadie J. Ryan	11
3	Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003 2019 ·Frontiers in Immunology ·Adam T. Waickman, Heather Friberg, (unknown), Amanda M. Kong, Mark E. Polhemus, Timothy P. Endy, Stephen J. Thomas, Richard G. Jarman, Jeffrey R. Currier	27
4	The Burden of Dengue Fever and Chikungunya in Southern Coastal Ecuador: Epidemiology, Clinical Presentation, and Phylogenetics from the First Two Years of a Prospective Study 2018 ·American Journal of Tropical Medicine and Hygiene ·Anna M. Stewart‐Ibarra, Sadie J. Ryan, Aileen Kenneson, Christine A. King, (unknown), Arturo Barbachano-Guerrero, Efraín Beltrán‐Ayala, Mercy J. Borbor‐Cordova, Washington B. Cárdenas, (unknown), Julia L. Finkelstein, (unknown), Richard G. Jarman, Irina Maljkovic Berry, Saurabh Mehta, Mark E. Polhemus, Mercy Silva, Timothy P. Endy	37
5	Successful malaria elimination in the Ecuador–Peru border region: epidemiology and lessons learned 2016 ·Malaria Journal ·Lyndsay Krisher, (unknown), (unknown), (unknown), Efraín Beltrán‐Ayala, (unknown), (unknown), Mark E. Polhemus, Fernando Quintana, Rosemary Rochford, Mercy Silva, Juan Bazo, Anna M. Stewart‐Ibarra	39
6	Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON®-TB Gold (+) Kenyan adults without evidence of tuberculosis 2016 ·Vaccine ·Douglas S. Walsh, (unknown), Mark E. Polhemus, Lucas Otieno, Ben Andagalu, Bernhards Ogutu, John Waitumbi, Anthony Hawkridge, Barbara Shepherd, Maria Grazia Pau, Jerald Sadoff, Macaya Douoguih, J. Bruce McClain	9
7	A global map of suitability for coastal Vibrio cholerae under current and future climate conditions 2015 ·Acta Tropica ·Luis E. Escobar, Sadie J. Ryan, Anna M. Stewart‐Ibarra, Julia L. Finkelstein, Christine A. King, Huijie Qiao, Mark E. Polhemus	81
8	Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study 2014 ·Malaria Journal ·Qigui Li, Shon Remich, Scott R. Miller, Bernhards Ogutu, Walter Otieno, Victor Meléndez, Paktiya Teja‐Isavadharm, Peter J. Weina, Mark Hickman, Bryan Smith, Mark E. Polhemus	11
9	Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice 2012 ·Vaccine ·Joanne M. Lumsden, Saule Nurmukhambetova, Jennifer Klein, Jetsumon Sattabongkot, Jason W. Bennett, Sylvie Bertholet, Christopher B. Fox, Steven G. Reed, Christian F. Ockenhouse, Randall F. Howard, Mark E. Polhemus, Anjali Yadava	30
10	Antimalarial Drug Sensitivity Profile of Western Kenya Plasmodium falciparum Field Isolates Determined by a SYBR Green I in vitro Assay and Molecular Analysis 2011 ·American Journal of Tropical Medicine and Hygiene ·Hoseah M. Akala, Fredrick Eyase, Agnes C. Cheruiyot, (unknown), Bernhards Ogutu, Norman C. Waters, Jacob D. Johnson, Mark E. Polhemus, David Schnabel, Douglas S. Walsh	38
11	Malaria prevalence defined by microscopy, antigen detection, DNA amplification and total nucleic acid amplification in a malaria‐endemic region during the peak malaria transmission season 2011 ·Tropical Medicine & International Health ·John Waitumbi, Jay Gerlach, Irina Afonina, Samuel B. Anyona, (unknown), (unknown), Irina Ankoudinova, Mitra C. Singhal, (unknown), Mark E. Polhemus, Nico Vermeulen, Walt Mahoney, (unknown), Gonzalo J. Domingo	16
12	Outpatient Upper Respiratory Tract Viral Infections in Children with Malaria Symptoms in Western Kenya 2010 ·American Journal of Tropical Medicine and Hygiene ·John Waitumbi, Jane Kuypers, Samuel B. Anyona, (unknown), Mark E. Polhemus, Jay Gerlach, Matthew C. Steele, Janet A. Englund, Kathleen M. Neuzil, Gonzalo J. Domingo	27
13	Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei 2010 ·PLoS ONE ·Elke S. Bergmann‐Leitner, (unknown), Patricia De La Vega, (unknown), Mark E. Polhemus, Christian F. Ockenhouse, Evelina Angov	95
14	Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area 2009 ·PLoS ONE ·Mark E. Polhemus, Shon Remich, Bernhards Ogutu, John Waitumbi, Lucas Otieno, (unknown), James F. Cummings, Kent E. Kester, Christian F. Ockenhouse, Ann Stewart, Opokua Ofori‐Anyinam, (unknown), (unknown), Marc Lievens, Marie‐Claude Dubois, Marie‐Ange Demoitié, Amanda Leach, Joe Cohen, W. Ripley Ballou, D. Gray Heppner	94
15	Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial 2009 ·PLoS ONE ·John Waitumbi, Samuel B. Anyona, (unknown), (unknown), Mark E. Polhemus, Douglas S. Walsh, Chris Ockenhouse, D. Gray Heppner, Amanda Leach, Marc Lievens, W. Ripley Ballou, Joe Cohen, Colin J. Sutherland	39
16	Persistence of Vaccinia at the Site of Smallpox Vaccination 2007 ·Clinical Infectious Diseases ·James F. Cummings, Mark E. Polhemus, (unknown), (unknown), George V. Ludwig, Glenn Wortmann	1
17	Hb Kenya among Luo Adults and Young Children in Malaria Holoendemic Western Kenya: Screened by High Performance Liquid Chromatography and Confirmed By Polymerase Chain Reaction 2007 ·Hemoglobin ·(unknown), Mark E. Polhemus, D. Gray Heppner, Mark R. Withers, Bernhards Ogutu, John Waitumbi	7
18	Old World Leishmaniasis: An Emerging Infection among Deployed US Military and Civilian Workers 2004 ·Clinical Infectious Diseases ·Peter J. Weina, Ronald C. Neafie, Glenn Wortmann, Mark E. Polhemus, Naomi Aronson	113
19	Lack of Vaccinia Viremia after Smallpox Vaccination 2004 ·Clinical Infectious Diseases ·James F. Cummings, Mark E. Polhemus, Clifton A. Hawkes, (unknown), George V. Ludwig, Glenn Wortmann	26
20	Persistent Nephrolithiasis After Discontinuation of Indinavir Therapy 1998 ·Clinical Infectious Diseases ·Mark E. Polhemus, Naomi Aronson	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact